Translocation of botulinum neurotoxin serotype A and associated proteins across the intestinal epithelia

Cellular Microbiology

Volumn 17, Issue 8, 2015, Pages 1133-1143

  Lam, Tina I ^a   Stanker, Larry H ^a   Lee, Kwangkook ^b   Jin, Rongsheng ^b   Cheng, Luisa W ^a  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; NEUROTOXIN ASSOCIATED PROTEIN; PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; MACROMOLECULE;

ANIMAL EXPERIMENT; ARTICLE; CLEARANCE; COLON; CONTROLLED STUDY; ELECTRIC RESISTANCE; FEMALE; HUMAN; HUMAN CELL; ILEUM; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; INTESTINE ABSORPTION; INTESTINE CRYPT; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE VILLUS; JEJUNUM; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECEPTOR BINDING; SMALL INTESTINE; TIGHT JUNCTION; TRANSCYTOSIS; ANIMAL; BIOLOGICAL MODEL; CACO-2 CELL LINE; EPITHELIUM CELL; INTESTINE MUCOSA; MACROMOLECULE; METABOLISM; TIME FACTOR;

ANIMALS; BOTULINUM TOXINS, TYPE A; CACO-2 CELLS; CARRIER PROTEINS; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; MACROMOLECULAR SUBSTANCES; MICE; MODELS, BIOLOGICAL; PROTEIN TRANSPORT; TIME FACTORS;

EID: 84937163658     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12424     Document Type: Article

References (40)

1. Ahsan, C.R., Hajnoczky, G., Maksymowych, A.B., and Simpson, L.L. (2005) Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells. J Pharmacol Exp Ther 315: 1028-1035.
2. Al-Saleem, F.H., Ancharski, D.M., Joshi, S.G., Elias, M., Singh, A., Nasser, Z., and Simpson, L.L. (2012) Analysis of the mechanisms that underlie absorption of botulinum toxin by the inhalation route. Infect Immun 80: 4133-4142.
3. Arnon, S.S., Schechter, R., Inglesby, T.V., Henderson, D.A., Bartlett, J.G., Ascher, M.S., etal. (2001) Botulinum toxin as a biological weapon: medical and public health management. JAMA 285: 1059-1070.
4. Bagramyan, K., Kaplan, B.E., Cheng, L.W., Strotmeier, J., Rummel, A., and Kalkum, M. (2013) Substrates and controls for the quantitative detection of active botulinum neurotoxin in protease-containing samples. Anal Chem 85: 5569-5576.
5. Barash, J.R., and Arnon, S.S. (2014) A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. J Infect Dis 209: 183-191.
6. Bigalke, H., and Rummel, A. (2005) Medical aspects of toxin weapons. Toxicology 214: 210-220.
7. Chen, F., Kuziemko, G.M., and Stevens, R.C. (1998) Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species. Infect Immun 66: 2420-2425.
8. Cheng, L.W., Onisko, B., Johnson, E.A., Reader, J.R., Griffey, S.M., Larson, A.E., etal. (2008) Effects of purification on the bioavailability of botulinum neurotoxin type A. Toxicology 249: 123-129.
9. Cheng, L.W., Stanker, L.H., Henderson, T.D., 2nd, Lou, J., and Marks, J.D. (2009) Antibody protection against botulinum neurotoxin intoxication in mice. Infect Immun 77: 4305-4313.
10. Couesnon, A., Molgo, J., Connan, C., and Popoff, M.R. (2012) Preferential entry of botulinum neurotoxin A Hc domain through intestinal crypt cells and targeting to cholinergic neurons of the mouse intestine. PLoS Pathog 8: e1002583.
11. Eisele, K.H., Fink, K., Vey, M., and Taylor, H.V. (2011) Studies on the dissociation of botulinum neurotoxin type A complexes. Toxicon 57: 555-565.
12. Fujinaga, Y. (2010) Interaction of botulinum toxin with the epithelial barrier. J Biomed Biotechnol 2010: 974943.
13. Fujinaga, Y., Matsumura, T., Jin, Y., Takegahara, Y., and Sugawara, Y. (2009) A novel function of botulinum toxin-associated proteins: HA proteins disrupt intestinal epithelial barrier to increase toxin absorption. Toxicon 54: 583-586.
14. Gu, S., Rumpel, S., Zhou, J., Strotmeier, J., Bigalke, H., Perry, K., etal. (2012) Botulinum neurotoxin is shielded by NTNHA in an interlocked complex. Science 335: 977-981.
15. Hasegawa, K., Watanabe, T., Suzuki, T., Yamano, A., Oikawa, T., Sato, Y., etal. (2007) A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms. J Biol Chem 282: 24777-24783.
16. Hill, K.K., Smith, T.J., Helma, C.H., Ticknor, L.O., Foley, B.T., Svensson, R.T., etal. (2007) Genetic diversity among botulinum neurotoxin-producing clostridial strains. J Bacteriol 189: 818-832.
17. Hines, H.B., Lebeda, F., Hale, M., and Brueggemann, E.E. (2005) Characterization of botulinum progenitor toxins by mass spectrometry. Appl Environ Microbiol 71: 4478-4486.
18. Inoue, K., Fujinaga, Y., Watanabe, T., Ohyama, T., Takeshi, K., Moriishi, K., etal. (1996) Molecular composition of Clostridium botulinum type A progenitor toxins. Infect Immun 64: 1589-1594.
19. Ito, H., Sagane, Y., Miyata, K., Inui, K., Matsuo, T., Horiuchi, R., etal. (2011) HA-33 facilitates transport of the serotype D botulinum toxin across a rat intestinal epithelial cell monolayer. FEMS Immunol Med Microbiol 61: 323-331.
20. Jin, Y., Takegahara, Y., Sugawara, Y., Matsumura, T., and Fujinaga, Y. (2009) Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins - differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C. Microbiology 155: 35-45.
21. Lee, K., Gu, S., Jin, L., Le, T.T., Cheng, L.W., Strotmeier, J., etal. (2013) Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity. PLoS Pathog 9: e1003690.
22. Lee, K., Zhong, X., Gu, S., Kruel, A.M., Dorner, M.B., Perry, K., etal. (2014) Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex. Science 344: 1405-1410.
23. Maksymowych, A.B., and Simpson, L.L. (1998) Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells. J Biol Chem 273: 21950-21957.
24. Maksymowych, A.B., and Simpson, L.L. (2004) Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells. J Pharmacol Exp Ther 310: 633-641.
25. Maksymowych, A.B., Reinhard, M., Malizio, C.J., Goodnough, M.C., Johnson, E.A., and Simpson, L.L. (1999) Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade. Infect Immun 67: 4708-4712.
26. Matsumura, T., Jin, Y., Kabumoto, Y., Takegahara, Y., Oguma, K., Lencer, W.I., and Fujinaga, Y. (2008) The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption. Cell Microbiol 10: 355-364.
27. Montecucco, C., and Schiavo, G. (1994) Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 13: 1-8.
28. Montecucco, C., Papini, E., and Schiavo, G. (1996) Bacterial protein toxins and cell vesicle trafficking. Experientia 52: 1026-1032.
29. Nikitas, G., Deschamps, C., Disson, O., Niault, T., Cossart, P., and Lecuit, M. (2011) Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin. J Exp Med 11: 2263-2277.
30. Ohishi, I., Sugii, S., and Sakaguchi, G. (1977) Oral toxicities of Clostridium botulinum toxins in response to molecular size. Infect Immun 16: 107-109.
31. Pentecost, M., Otto, G., Theriot, J.A., and Amieva, M.R. (2006) Listeria monocytogenes invades the epithelial junctions at sites of cell extrusion. PLoS Pathog 2: e3.
32. Pentecost, M., Kumaran, J., Ghosh, P., and Amieva, M.R. (2010) Listeria monocytogenes invades the epithelial junctions at sites of cell extrusion. PLoS Pathog 6: e1000900.
33. Sakaguchi, G. (1982) Clostridium botulinum toxins. Pharmacol Ther 19: 165-194.
34. Scarlatos, A., Welt, B.A., Cooper, B.Y., Archer, D., DeMarse, T., and Chau, K.V. (2005) Methods for detecting botulinum toxin with applicability to screening foods against biological terrorist attacks. J Food Sci 70: 121-130.
35. Schiavo, G., Santucci, A., Dasgupta, B.R., Mehta, P.P., Jontes, J., Benfenati, F., etal. (1993) Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett 335: 99-103.
36. Simpson, L. (2013) The life history of a botulinum toxin molecule. Toxicon 68: 40-59.
37. Stanker, L.H., Scotcher, M.C., Cheng, L., Ching, K., McGarvey, J., Hodge, D., and Hnasko, R. (2013) A monoclonal antibody based capture ELISA for botulinum neurotoxin serotype B: toxin detection in food. Toxins 5: 2212-2226.
38. Sugawara, Y., Matsumura, T., Takegahara, Y., Jin, Y., Tsukasaki, Y., Takeichi, M., and Fujinaga, Y. (2010) Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin. J Cell Biol 189: 691-700.
39. Sugii, S., Ohishi, I., and Sakaguchi, G. (1977) Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes. Infect Immun 16: 910-914.
40. Yao, G., Lee, K., Gu, S., Lam, K.H., and Jin, R. (2014) Botulinum neurotoxin A complex recognizes host carbohydrates through its hemagglutinin component. Toxins 6: 624-635.